DR Horton Inc
XMUN:HO2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DR Horton Inc
XMUN:HO2
|
US |
|
Arbutus Biopharma Corp
NASDAQ:ABUS
|
US |
|
GuocoLand Ltd
SGX:F17
|
SG |
|
N
|
NP Inc
KOSDAQ:291230
|
KR |
|
Hampton Financial Corp
XTSX:HFC
|
CA |
|
Marui Group Co Ltd
F:MUI
|
JP |
|
C
|
Compugates Holdings Bhd
KLSE:COMPUGT
|
MY |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is HO2's stock price target?
Not Available
HO2 doesn't have any price targets made by Wall Street professionals.
What is DR Horton Inc's Revenue forecast?
Projected CAGR
5%
For the last 13 years the compound annual growth rate for DR Horton Inc's revenue is 17%. The projected CAGR for the next 3 years is 5%.
What is DR Horton Inc's Operating Income forecast?
Projected CAGR
5%
For the last 13 years the compound annual growth rate for DR Horton Inc's operating income is 25%. The projected CAGR for the next 3 years is 5%.
What is DR Horton Inc's Net Income forecast?
Projected CAGR
9%
For the last 13 years the compound annual growth rate for DR Horton Inc's net income is 11%. The projected CAGR for the next 3 years is 9%.